St. Mary’s Medical Center Enrolls First Florida Patient in the Trevo® Retriever RegistryJan 5, 2015
International study will evaluate clot retrieval technology in acute ischemic stroke patients
West Palm Beach, Fla. (January 5, 2015) – St. Mary’s Medical Center, a member of the Advanced Neuroscience Network (ANN), is participating in a new clinical trial to collect real-world performance data of the Stryker Neurovascular Trevo® Retrieval System. The retriever is a minimally invasive device intended to restore blood flow in the brain by removing blood clots in patients experiencing acute ischemic stroke.
The Trevo® Retriever Registry may enroll a maximum of 300 patients at up to 40 sites worldwide. The registry will assess the revascularization status of patients treated with the Trevo® Retriever at the end of the procedure and measure functional outcomes at 90 days post-procedure using the modified Rankin Scale (mRS).
“Being the first hospital in Florida to enroll a patient in this trial demonstrates our commitment to advancing the treatment of stroke,” said Davide Carbone, CEO of St. Mary’s Medical Center. “We are proud to contribute to the Trevo® Retriever Registry and continue to provide our patients with the latest in medical technology.”
In the United States, there are an estimated 795,000 strokes every year. Stroke is the fourth most common cause of death and the leading cause of adult disability in the United States.
“Every minute counts in terms of stroke treatment,” said Dr. Ali Malek, the study’s principal investigator and medical director of the Stroke Program at St. Mary’s. “As a Neuroscience Center of Excellence, we are dedicated to clinical research and expanding options for acute ischemic stroke patients.”
The Trevo® Retrieval System was granted 510(k) market clearance by the U.S. Food and Drug Administration (FDA) in October 2012.
For more information about the study, please contact the Clinical Research Coordinator, Murline Smith, at email@example.com or call her at 561-623-4980, ext. 275.